Aurobindo Pharma Limited has received its first approval from Swissmedic, Government of Switzerland for the licences of Finasteride APL tablets 5mg.
Finasteride APL tablets 5mg is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.